• About
  • Companies
  • Technology & AI
  • Who We Serve
  • Investors
  • Contact

Wellgistics President Releases Letter to Shareholder on Emerging Patient Care-Centric Strategic Direction

TAMPA, FL / ACCESS Newswire / March 13, 2026 / Wellgistics Health, Inc. (NASDAQ:WGRX) (“Wellgistics”), a health information technology leader, integrating proprietary pharmacy dispensing optimization artificial intelligence (AI) platform EinsteinRx™...

Wellgistics Strengthens PharmacyChain™ with Insurance Eligibility & Benefits Verification Capabilities

Medical insurance eligibility and benefits verification (EBV) is a core health technology capability necessary for PharmacyChain™ to gain market adoptionEBV services offering enabled with preferred pricing being made immediately available to providers, partners...

Wellgistics Targets $70B Market Breakthrough Addressing Ozempic / GLP-1 Muscle Loss with Forzet™

GLP-1 agonist market expected to grow from $70B in 2025 to $201B in 20301Proprietary Forzet formulation provides pharmacists, physicians and patients with unique solution for GLP-1 drugs’ primary side effectForzet targeting preservation of muscle while on GLP-1...

Wellgistics Health Selects Top Five Blockchain Platforms to Initiate Patent Protected PharmacyChain™ Smart Contracts-enabled Pharmaceutical Drug Tracking System to Support Industry-wide Serialization Mandate

Hyperledger Fabric, Ethereum/Polygon, VeChain, Quorum /Besu and Corda (R3) selected as most suitable blockchain platforms to build PharmacyChain™U.S. prescription drugs market project to grow from $634 billion market to $883 billion by 2030 according to...

DataVault AI and Wellgistics Health Announce Plans to Expand Partnership to Include Healthcare Delivery Intellectual Property for Healthcare as a Service (HaaS) Blockchain-enabled Smart Contracts

The global blockchain in healthcare market is projected to grow from $11 billion in 2024 to $214 billion by 2030, with annual growth rates expected to exceed 60%Ongoing PharmacyChain® technology build-out already involves key technology components necessary to...
« Older Entries
Next Entries »

Recent Posts

  • DataMeds AI Litigation Settlement Extinguishes ~$19 million In Liabilities and Retires 364,099 Common Sharessked
  • DataMEDS, AI. Acquires Helomics AI Cancer Diagnostics Lab and Precision Oncology CRO Businesses from Axe Compute
  • Datameds, AI., and Tollo Health Partner with the NFL Alumni Association for Health Lives Here National Campaign Rollout
  • CORRECTION FROM SOURCE: DataMeds AI and Tollo Health Announce Fall 2026 Cold & Flu #Back2School50% Marketing Campaign for Viral Infections Medical Food Galectovid™
  • DataMeds AI and Tollo Health Announce Fall 2026 Cold & Flu #Back2School50% Marketing Campaign for Viral Infections Medical Food Galectovid™

Recent Comments

No comments to show.

© 2026 DataMEDS AI. All Rights Reserved.

  • Follow
  • Follow